Menopause hormone therapy is everywhere right now, and we sort science from hype using the newest ACP and ACOG guidance. We explain why the treatment is often simpler than social media claims, and how to spot hormone grift without dismissing real symptoms.

• menopause hype and the rise of cash-pay menopause clinics
• the medical hype cycle and how WHI shaped fear and overcorrection
• ACP guideline: estrogen with progestogen first line for vasomotor symptoms when a uterus is present
• nonhormonal options and where SSRIs, SNRIs, gabapentin, and neurokinin receptor antagonists fit
• route myths: why transdermal is not proven “safer” than oral for rare harms
• ACOG guidance on vasomotor symptoms, sleep disturbance, mood symptoms, timing of initiation, and contraindications
• perimenopause management: contraception-based ovarian suppression versus MHT supplementation
• why routine hormone testing, AMH, saliva, urine, and dried urine panels do not guide care
• testosterone reality check: limited indications, superphysiologic dosing, and potential cardiovascular risk
• four red flags for social media hormone grifters: broad cure-all claims, hormone testing products, compounded hormones and pellets, excessive testosterone

Be sure to check out thinking about obgyn.com for more information, and be sure to follow us on Instagram.

0:01 Why Menopause Is Everywhere

5:54 The Hype Cycle Behind Hormones

11:12 ACP Guideline First Line Treatment

14:41 Transdermal Versus Oral Risk Claims

17:54 ACOG Vasomotor Sleep Mood Guidance

26:46 Perimenopause Toolkit And Lab Testing

32:05 Testosterone Risks And Overuse

34:19 Four Red Flags For Hormone Grifters

Follow us on Instagram @thinkingaboutobgyn.